We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 236,233 | 07:44:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/8/2020 10:30 | Two different applications. the lysate comes from a combination of gut bacteria which is made into lysate for application via the cream. The psoriasis is ingested mix of bacteria that specifically target the cause of psoriasis. I had recently mailed SA as my step daughter suffers from eczema to see what the similarity or differences are. He explained that due to a deficiency in the gut for psoriasis there are too many skin cells produced and this causes the scaling of the skin. The pathway for the five different types of eczema are each different and different to psoriasis. | gary hindsight | |
06/8/2020 10:18 | Anyone know whether the lysate tech Is tied in with the psarios probiotic, or are they two different applications? | anderson3 | |
06/8/2020 09:55 | 06/08/2020 Cath O'Niell, chief scientific officer at SkinBioTherapeutics and professor of translational dermatology at the University of Manchester, sits down to discuss her latest research and how probiotics might be a new viable therapy for other inflammatory skin disease besides psoriasis. | scotty1 | |
06/8/2020 09:21 | Absolutely nothing offered on the RSP whilst they are bidding up for masses. Going up.... | nobbygnome | |
06/8/2020 08:57 | MadNot just committed in writing but have actually build it, produced the lysate and successfully tested the results.Chris I do get your caution though, it's easy to get carried away as I have learnt in the past to my cost but there does seem to be so many positive pointers here. Time will tell of course but I am not seeing what could de-rail this at the moment | gary hindsight | |
06/8/2020 08:49 | It is hard to contemplate a FTSE 100 1.4 billion pound company committing in writing to building a multi million pound dedicated production line if they didn't believe there was significant payback. IMHO. I personally think that Axisbiotix is a considerably bigger opportunity for huge revenue. Watch Stuart's face when he starts talking about that sector and the size. DYOR GLA | madaboutmed | |
06/8/2020 08:43 | Secretly I also think when but I have been burnt on a few things in the past | christopher logsdon | |
06/8/2020 08:41 | I think that's just a when not an if | gary hindsight | |
06/8/2020 08:29 | If and when Croda manage to sell the product to all the Big boys this thing will fly | christopher logsdon | |
05/8/2020 11:25 | Bearing in mind the recent excellent news flow and subsequent interviews and the fact that the management team has shown real resilience to the pandemic and are actually ahead of schedule this still looks really cheap to me. Once that supplement trial starts there will be no buying in cheap again. Beggars belief that people are selling down IMHO DYOR GLA | madaboutmed | |
05/8/2020 11:12 | Robo, I really hope it works out for him and all of us holders. | rafboy | |
05/8/2020 10:25 | Dad just topped up 5400 worth half hour ago , he's happy , £1000 of that was profit from something else , he's about £60,000 here and Opti , this could very well set him up for his retirement, he's a crane driver and never really massed any wealth, Sbtx and out hit a pound that's him sitting pretty . GLA | robo28 | |
05/8/2020 10:07 | low volume day, recently low volume days are red high volume blue which is a positive trend. robo i know of someone waiting for funds to drop so they too will be happy, he was furious he wasnt paid last week.... | shrewdmole | |
05/8/2020 09:10 | And there is one buy of 440 shares :-)As per posts last night at the moment I can't see a reason to sell although every one has there own reasons. As I saw on a post the other there are many reasons to sell but only one reason to buy | gary hindsight | |
05/8/2020 09:06 | Yeah not a good start to the day. At least my gold shares are positive today | gary hindsight | |
05/8/2020 09:06 | Let them , my dad will be over the moon , he was waiting for some funds to clear , will get in a lot cheaper now , also I'll get my self employed furlough in a week or so , I'll be able to top up at a much better price | robo28 | |
05/8/2020 09:03 | These Guys should be buying not selling 🤷a | judijudi | |
05/8/2020 07:48 | Robbo Very nice rns. I’ve posted on Opti bb but no way a huge player like them extend terms unless they are confident. Let’s not forget they are the Australian number one weight loss company. S | shrewdmole | |
05/8/2020 07:39 | Well nice rns for Opti this morning, I think topping you there was a good idea, slowly but surly Opti is going global | robo28 | |
05/8/2020 07:00 | Guys sounds like many here hold Opti and sbtx. For me Opti entered a very competitive market and have taken time to establish the science behind slimbiome. Soh has taken his time to spread the risk by using multiple manufacturers, sales outlets. I can’t knock this and in time it’s worked, I believe not many deals will be cancelled due to performance. However skinbiotix for one example has been done with one global player with 12,000 clients for a very in demand product for anti ageing. It’s likely this will be added to several global established brands over the net year or two who will spend multi millions on advertising (that’s the biggest difference) L’Oréal or whomever will add skinbiotix with proven science and added barrier protection and it will be all over tv and press worldwide. That’s why I think revenue growth will be quicker here. I’m in both and have actually been picki up a few Opti whilst it’s been unloved. I actually think Opti is due a rerate soon, way too much Nd king on just has too many stale bulls. I’d like to see them bring in cenkos. A | shrewdmole | |
05/8/2020 06:46 | Yeah the thing being lots of people don't t seem to mind being fat,as even with Opti's products there is no quick fix but I can't imagine any eczema or psoriasis sufferer who who wouldn't pay to pop a pill to get rid of it . Also S.A. has done his research with the psoriasis community and sounds like they have ready and waiting consumers chomping at the bit to get the product, can't remember Opti having that | robo28 | |
04/8/2020 23:22 | Totally agree nik it's why I started on a more conservative tack and maybe it's only 10% clients conversion but the single application of this lysate is just the beginning of its uses and of only one pillar of the business. SA talked about oral health, hair and others as well as eczema and other skin complaintsI and others have been disappointed but accepted the pace of revenue growth at opti which I believe will still come good in due course. I opined on that board that I felt sbtx would have faster revenue growth. I do believe it's different this time but have been wrong before so time will tell | gary hindsight |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions